Programs

Click on the links below to learn more about the Programs in the NCI Alliance for Nanotechnology in Cancer.

• Centers of Cancer Nanotechnology Excellence (CCNEs) – NCI has awarded eight multi-institutional hubs that will focus on integrating nanotechnology into basic and applied cancer research and providing new solutions for the diagnosis and treatment of cancer.

• Cancer Nanotechnology Platform Partnerships – NCI has awarded twelve partnerships that are designed to develop technologies for new products in six key programmatic areas: molecular imaging and early detection, in vivo imaging, reporters of efficacy, multifunctional therapeutics, prevention and control, and research enablers.

• Multidisciplinary Research Training and Team Development – The NCI has developed training programs to encourage the growth of an interdisciplinary, nanotechnology workforce and to support the research teams working on NCI-funded nanotechnology projects.

• Nanotechnology Characterization Laboratory (NCL) – The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the pre-clinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry.